Suchen und filtern

Gefundene Studien

METAPANC Intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus systemic chemotherapy alone: a randomized controlled phase 3 trial (METAPANC) AIO-PAK-0219 · In Vorbereitung Studie anzeigen

ESPAC-6 An open labelled phase III adjuvant trial of disease-free survival in patients with resected pancreatic ductal adenocarcinoma randomized to allocation of oxaliplatin- or gemcitabine-based chemotherapy by standard clinical criteria or by a transcriptomic treatment specific stratification signature - ESPAC-6 AIO-PAK-0121/ass · In Vorbereitung Studie anzeigen

ANTONIO Perioperative/Adjuvant atezolizumab with or without the immunomodulatory IMM-101 in patients with MSI-high or MMR-deficient stage III colorectal cancer ineligible for oxaliplatin-based chemotherapy– a randomized Phase II study AIO-KRK-0220 · In Rekrutierung Studie anzeigen

MEFOX A phase I/II trial of methadone hydrochloride and mFOLFOX6 in the treatment of advanced colorectal cancer AIO-KRK-0119 · In Rekrutierung Studie anzeigen

ADJUBIL A Phase II study of immunotherapy with durvalumab and tremelimumab in combination with capecitabine or without capecitabine in ADJUvant situation for BILiary tract cancer AIO-HEP-0421/ass · In Vorbereitung Studie anzeigen

Break B5-BM-NSCLC Breaking the big Five Barriers of Brain Metastasis: A prospective phase II, open-label, multi-center trial of combined nivolumab, ipilimumab and bevacizumab together with 2 cycles of induction chemotherapy in patients with non-squamous non-small-cell lung cancer (NSCLC) metastatic to the brain (Break B5-BM NSCLC Trial) AIO-TRK-0220/ass · In Vorbereitung Studie anzeigen

AIO-SUP-0121 Quality Assurance on Anemia Management in Patients with Solid Tumors and Malignant Lymphoma - finished AIO-SUP-0121 · Rekrutierung beendet Studie anzeigen

MOONLIGHT Modified FOLFOX plus/minus Nivolumab and Ipilimumab vs. FLOT plus Nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction – A randomized phase 2 trial. [MOONLIGHT] AIO-STO-0417 · Rekrutierung beendet Studie anzeigen

FIRE-9/PORT Post-resection/ablation chemotherapy in patients with metastatic colorectal cancer (FIRE9/PORT) AIO-KRK-0418 · In Rekrutierung Studie anzeigen

GOBLET A phase 1 / 2 multiple-indication biomarker, safety, and efficacy study in advanced or metastatic Gastrointestinal cancers explOring treatment comBinations with peLarEorep and aTezolizumab AIO-KRK-0320ass · In Rekrutierung Studie anzeigen